
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
A shift in cancer treatment methodology makes a world of difference. Oniria Therapeutics is a spin-off from Vall dHebron Institute of Oncology (VHIO), the University of Barcelona (UB) and the Catalan Institution for Research and Advanced Studies (ICREA). Oniria Therapeutics is a biotech company focused on the development of first-in-class drugs in the field of precision oncology. It develops therapies to modulate and eliminate dormant tumor cells as a novel targeted strategy to overcome their persistence. Our flagship product allosterically activates TET2, a master epigenetic enzyme
Biotechnology,cancer,cell dormancy,first-in-class,biopharmaceutical,precision oncology,cancer persistence,spin-off,targeted therapy,and tet2
Oniria therapeutics operates in the Biotechnology research industry.
Oniria therapeutics's revenue is 11m - 100m
Oniria therapeutics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.